The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...

Apple's latest AirPods are officially here. The AirPods Pro 3 have been a long time coming – three years, in fact – but it looks like they might just be worth the wait. The new flagships offer ...

So, is the iPhone 17 worth it? The new model starts at $829, but here's the kicker: Apple finally did away with the measly ...

You can compare two versions of the same Word document using a built-in tool to see how a document has been modified.

Few differences were found for cardiovascular, kidney, and mortality outcomes between liraglutide, semaglutide, and dulaglutide for patients with type 2 diabetes.

IV ketamine for severe resistant depression is associated with a more rapid response and greater reduction of symptoms than ...

When Chevrolet introduced its 350 cubic-inch small block engine in 1967, it started a phenomenon that lasts even today. Pontiac's 350, introduced in 1968, never saw the same success and was phased out ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor ...

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

Objective To assess evidence of overall survival (OS) benefits of cancer drugs listed in China’s National Reimbursement Drug ...